From the beginning of this drama going on a month ago, the White House has been laser-focused on shutting down government-supported medical research in the United States. Of course, much of that is research into cancer cures or fundamental research building toward the same. The precise goal of all this shutting down is difficult to uncover — likely one half an effort to destroy or exercise control over academic/research institutions mixed with post-COVID hostility to medical research itself. On paper the effort was put on hold by a mix of the White House backing off and the original orders being blocked by judges. But in fact the White House has found very effective workarounds to evade the impact of those court orders. And that evasion, or those alternative paths to shutting down research grants, has accelerated or clamped down even harder this week.
